Literature DB >> 26597614

Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy.

J Alfred Witjes1.   

Abstract

Radical cystectomy is the standard treatment for patients with bladder cancer, but the prognosis of patients undergoing this procedure has not changed for decades. Small steps towards improvement include better selection of high-risk T1 patients, the use of perioperative chemotherapy and, maybe, robotic cystectomy.

Entities:  

Mesh：

Year:  2015        PMID： 26597614     DOI： 10.1038/nrurol.2015.272

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  10 in total

Review 1.  Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy.

Authors:  Giacomo Novara; James W F Catto; Timothy Wilson; Magnus Annerstedt; Kevin Chan; Declan G Murphy; Alexander Motttrie; James O Peabody; Eila C Skinner; Peter N Wiklund; Khurshid A Guru; Bertram Yuh
Journal:  Eur Urol       Date:  2015-01-02       Impact factor: 20.096

2.  Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Authors:  Homayoun Zargar; Patrick N Espiritu; Adrian S Fairey; Laura S Mertens; Colin P Dinney; Maria C Mir; Laura-Maria Krabbe; Michael S Cookson; Niels-Erik Jacobsen; Nilay M Gandhi; Joshua Griffin; Jeffrey S Montgomery; Nikhil Vasdev; Evan Y Yu; David Youssef; Evanguelos Xylinas; Nicholas J Campain; Wassim Kassouf; Marc A Dall'Era; Jo-An Seah; Cesar E Ercole; Simon Horenblas; Srikala S Sridhar; John S McGrath; Jonathan Aning; Shahrokh F Shariat; Jonathan L Wright; Andrew C Thorpe; Todd M Morgan; Jeff M Holzbeierlein; Trinity J Bivalacqua; Scott North; Daniel A Barocas; Yair Lotan; Jorge A Garcia; Andrew J Stephenson; Jay B Shah; Bas W van Rhijn; Siamak Daneshmand; Philippe E Spiess; Peter C Black
Journal:  Eur Urol       Date:  2014-09-23       Impact factor: 20.096

Review 3.  Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.

Authors:  Jeffrey J Leow; William Martin-Doyle; Padma S Rajagopal; Chirayu G Patel; Erin M Anderson; Andrew T Rothman; Richard J Cote; Yuksel Urun; Steven L Chang; Toni K Choueiri; Joaquim Bellmunt
Journal:  Eur Urol       Date:  2013-08-28       Impact factor: 20.096

Review 4.  Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel.

Authors:  Timothy G Wilson; Khurshid Guru; Raymond C Rosen; Peter Wiklund; Magnus Annerstedt; Bernard H Bochner; Kevin G Chan; Francesco Montorsi; Alexandre Mottrie; Declan Murphy; Giacomo Novara; James O Peabody; Joan Palou Redorta; Eila C Skinner; George Thalmann; Arnulf Stenzl; Bertram Yuh; James Catto
Journal:  Eur Urol       Date:  2015-01-09       Impact factor: 20.096

Review 5.  Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.

Authors:  Sven van den Bosch; J Alfred Witjes
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

6.  The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.

Authors:  Robert S Svatek; Shahrokh F Shariat; Robert E Lasky; Eila C Skinner; Giacomo Novara; Seth P Lerner; Yves Fradet; Patrick J Bastian; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Stefan C Müller; Jonathan I Izawa; Vincenzo Ficarra; Arthur I Sagalowsky; Mark P Schoenberg; Arlene O Siefker-Radtke; Randall E Millikan; Colin P N Dinney
Journal:  Clin Cancer Res       Date:  2010-07-22       Impact factor: 12.531

Review 7.  Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients.

Authors:  William Martin-Doyle; Jeffrey J Leow; Anna Orsola; Steven L Chang; Joaquim Bellmunt
Journal:  J Clin Oncol       Date:  2015-01-05       Impact factor: 44.544

8.  Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.

Authors:  Bernard H Bochner; Guido Dalbagni; Daniel D Sjoberg; Jonathan Silberstein; Gal E Keren Paz; S Machele Donat; Jonathan A Coleman; Sheila Mathew; Andrew Vickers; Geoffrey C Schnorr; Michael A Feuerstein; Bruce Rapkin; Raul O Parra; Harry W Herr; Vincent P Laudone
Journal:  Eur Urol       Date:  2014-12-08       Impact factor: 20.096

9.  Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

Authors:  Cora N Sternberg; Iwona Skoneczna; J Martijn Kerst; Peter Albers; Sophie D Fossa; Mads Agerbaek; Herlinde Dumez; Maria de Santis; Christine Théodore; Michael G Leahy; John D Chester; Antony Verbaeys; Gedske Daugaard; Lori Wood; J Alfred Witjes; Ronald de Wit; Lionel Geoffrois; Lisa Sengelov; George Thalmann; Danielle Charpentier; Frédéric Rolland; Laurent Mignot; Santhanam Sundar; Paul Symonds; John Graham; Florence Joly; Sandrine Marreaud; Laurence Collette; Richard Sylvester
Journal:  Lancet Oncol       Date:  2014-12-11       Impact factor: 41.316

10.  Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.

Authors:  Zachary D Reardon; Sanjay G Patel; Harras B Zaid; C J Stimson; Matthew J Resnick; Kirk A Keegan; Daniel A Barocas; Sam S Chang; Michael S Cookson
Journal:  Eur Urol       Date:  2014-01-23       Impact factor: 20.096
  10 in total
  9 in total

1.  Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer.

Authors:  Wenwen Zhong; Hu Qu; Bing Yao; Dejuan Wang; Jianguang Qiu
Journal:  Cureus       Date:  2022-05-08

2.  Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway.

Authors:  Sandeep Shrestha; Jiabin Zhu; Qi Wang; Xiaohui Du; Fen Liu; Jianing Jiang; Jing Song; Jinshan Xing; Dongdong Sun; Qingjuan Hou; Yulin Peng; Jun Zhao; Xiuzhen Sun; Xishuang Song
Journal:  Int J Oncol       Date:  2017-08-22       Impact factor: 5.650

3.  Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.

Authors:  Cheng Hu; Ying Liu; Yuan Lin; Jian-Kai Liang; Wen-Wen Zhong; Ke Li; Wen-Tao Huang; De-Juan Wang; Guang-Mei Yan; Wen-Bo Zhu; Jian-Guang Qiu; Xin Gao
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 4.  Melatonin and urological cancers: a new therapeutic approach.

Authors:  Mohammad Hossein Mehrzadi; Azam Hosseinzadeh; Kobra Bahrampour Juybari; Saeed Mehrzadi
Journal:  Cancer Cell Int       Date:  2020-09-10       Impact factor: 5.722

5.  UBIAD1 suppresses the proliferation of bladder carcinoma cells by regulating H-Ras intracellular trafficking via interaction with the C-terminal domain of H-Ras.

Authors:  Zhiliang Xu; Fengsen Duan; Huiai Lu; Maytham Abdulkadhim Dragh; Yanzhi Xia; Huageng Liang; Ling Hong
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

6.  Development and Validation of a Prognostic Nomogram for Predicting Overall Survival for T1 High-Grade Patients After Radical Cystectomy: A Study Based on SEER.

Authors:  Xiangpeng Zhan; Luyao Chen; Ming Jiang; Bin Fu
Journal:  Int J Gen Med       Date:  2022-04-05

Review 7.  The Oncobiome in Gastroenteric and Genitourinary Cancers.

Authors:  Domenica Lucia D'Antonio; Simona Marchetti; Pamela Pignatelli; Adriano Piattelli; Maria Cristina Curia
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

8.  Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways.

Authors:  Fengsen Duan; Yuejin Yu; Rijian Guan; Zhiliang Xu; Huageng Liang; Ling Hong
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

9.  Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways.

Authors:  Kaiyu Qian; Gang Wang; Rui Cao; Tao Liu; Guofeng Qian; Xinyuan Guan; Zhongqiang Guo; Yu Xiao; Xinghuan Wang
Journal:  Molecules       Date:  2016-10-21       Impact factor: 4.927
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.